India's Leading Pharmaceutical Companies to Watch in 2020

India's Leading

Pharmaceutical Companies to Watch in 2020

Century Pharmaceuticals Limited

Managing Director

www.primeview.co

CrescoHR Pvt.Ltd.

India’s leading and fastest growing HR Consulting firm

Services to IT and Non IT Sectors :• • • •

Staffing Recrutiment HR Consulting Training & Development

CrescoHR Pvt Ltd 2nd Floor, 'B' Wing, Office No. 5, Destination Center, Magarpatta City, Hadapsar Pune - 411 013 (India)

Tele : +91 8087311666 Mobile : +91 7756900666, +91 7756800666 E-mail : info@crescohr.com Website : www.crescohr.com

Editors Note

India's Leading

Pharmaceutical Companies to Watch in 2020

Century Pharmaceuticals Limited

Managing Director

www.primeview.co

The Indian pharmaceutical industry is witnessing immense growth. The industry saw a double digit growth in June 2014. With 10,500 manufacturing units and over 3,000 pharmaceutical companies, the Indian pharmaceutical industry is among the top six producers of pharmaceuticals in the world. The country’s pharmaceutical exports stood at $14.7 billion in 2012-13, at a growth rate of 11 per cent and it is slated to increase to $25 billion by 2016.With a vision of making India a global leader in end-to-end manufacturing by 2020, there are several steps taken by the Government of India such as weighted tax deduction of 150 per cent for any R&D expenditure incurred. Along with this, the government has also made tax breaks available to the pharmaceutical sector.

However with all support from the government, the industry is heading to saturation and is striving to cope up with the predictions. The root cause is the lack of implementation of current technologies. The need for adopting and also evolving along with the time has become critical in order to achieve success. Nevertheless, the market has several pharmaceutical software solution companies that are coming up with new and innovative solutions to aid the pharmaceutical industry to keep up with the times. The technology provided by these solution providers is the boost the pharmaceutical companies need in order to excel in the market and thrive.

Having interacted with several technology heads and business leaders from the pharma industry, we at Prime View Magazine realized the need to identify the best solution providers for the pharmaceutical and biotechnology industry. We present to you the ‘India's Leading Pharmaceutical Companies to Watch in 2020’. This comprehensive list intends to help you chose the solution provider for your specific needs. A distinguished panel comprising of CEO’s, CIO’s, industry analysts and Prime View editorial team scrutinized various companies before finalizing the Top names.

Happy Reading Prime View Magazine

India's Leading Pharmaceutical Companies to Watch in 2020

VIDYA V W

UMESH B SUSMA K

PRATIK T. , VISHNU J.

SOPAN K.

RISHIKESH D.

Megha D. , Dhanashri A.

Visit: https://primeview.co Email: editor@primeview.co

Cover Story CENTURY PHARMACEUTICALS LTD

THE PRODUCTIVE, PROGRESSIVE AND PRICECONSCIOUS NAME OF INDIAN PHARMACEUTICAL

8

Contents Sushiel Agrawal

20

INDIAN HERBS SPECIALITIES PVT LTD TACKLING THE NEEDS OF ANIMAL HEALTH INDUSTRY WITH AYURVEDA

Arun Agarwal

26

JANITRI INNOVATIONS PVT. LTD. EXCEPTIONAL TECH-BASED INNOVATIONS BASED HEALTHCARE

32 ROLEX LANOLIN PRODUCTS LIMITED PRODUCING A DIVERSE PORTFOLIOOF ICONIC LANOLIN AND ALLIED PRODUCTS WITH EXCELLENT QUALITY

Articles Investment Opportunities in the Pharmaceutical Industry in India

18

Top Pharmaceutical Companies in india , you should know

24

The Trials and Tribulations in Pharmaceutical Sector of India

30

Top Technology Innovation in Pharma Industry of India

36

Cover Story

Century Pharmaceuticals Limited

Managing Director

8

THE PRODUCTIVE, PROGRESSIVE AND PRICE-CONSCIOUS NAME OF INDIAN PHARMACEUTICAL

I

ndian Pharmaceutical Industry has symbolically positioned itself as the next biggest in terms of quantity and the thirteen largest regarding values globally going by the report of Equity Master. The industry has mapped a long path from being of prime importance in the 1950s to a manufacturing hub of active pharmaceutical ingredients today. The major ingredients powering and fueling the growth of the Indian Pharma, the Indian Pharmaceutical companies are burgeoning and the credit goes to increased government expenses on health and the increasing health awareness amongst its people. Among the domain, with its commitment of resolving health issues by delivering value-added and cost-effective health solutions to people, Century Pharmaceuticals has flung its wings as one of the largest pharmaceutical companies established in the year 1982 and evolving as a supplier of repute for APIs to the global pharmaceutical companies in India and abroad.

Perpetually dedicated to API Products, API-Research, Animal Health, and Biotechnology, Century Pharmaceuticals has clocked a tremendous growth over its stretch of 39 years as a reputed and renowned organization. Under the hegemony of Dr. Janak Sheth, Managing Director, the firm has underscored its commitment to creating value for all their customers, partners, and employees while applying environment-friendly and socially responsible business practices fostering ‘Excellence’.

The USP of Century Pharmaceuticals includes quality, regulatory support, timely delivery and quick response to customer queries that make it stand out in the market. Through collaborations and partnerships, innovative research and contract research services, they are working for customers to leverage their expertise and experience to produce products and services cost-effectively and with greater reliability.

9

THE MAN BEHIND THE BRAND An entrepreneur, a leader and a proactive business partner, Dr. Janak Sheth has taken the fortunes of Century Pharmaceuticals to be recognised as a pharmaceutical industry of repute and recognition in India. He holds over 4 decades of industry experience and has been quite active in the industry circles fighting for the MSME sector and also towards building exports from India by taking several delegations abroad especially in new markets.

As a respected professional in the industry, he has been invited to several forums for his views on the industry and to encourage young professionals in academia and industry. In academics, Dr. Janak Sheth did B. Tech from IIT, Delhi and a Hon PhD from a South Korean University

PRODUCTS ON OFFER

Initially, Century Pharmaceuticals started manufacturing APIs with only three products, and the product range has grown to a wide basket of products with different therapeutic segments- Acenocoumarol, Amlodipine Besylate, Azithromycin Dihydrate, Bimatoprost, Empagliflozin, Erythromycin, and all its salts, Flibensarin, Fluticasone Propionate, Gramicidin, Latanoprost, Oxytetracycline, Palonosetron Hcl, Tadalafil, etc to name a few.

Moreover, they are developing new products in their R&D with a focus on low volume and high prices.

They are also engaged in a drug discovery program for recombinant fusion proteins for the treatment and cure for Asthma and Allergies. Century Pharmaceuticals has been also involved in Stem cell research for the last 6 years for the treatment of various lifestyle and other diseases for which there is no cure today.

10

OVERCOMING THE HICCUPS

Century has to face stiff and unhealthy competition from China. The costs in China are much lower owing to relaxation in effluent treatment standards, lower cost of capital and export rebates. However, owing to consistency in quality and service the company is able to offset a major part of this challenge.

Another major issue is finding a perfect business partner for their novel molecule for Asthma and Allergy. It is truly a unique molecule with a future owing to the targeted therapy approach. But large Indian companies are not interested in investing in research and hence we have yet to be able to encash the true potential of this molecule.

CLIENTELE

The partial list of customers includes Pfizer, Abbott, Glenmark, Polfarma, Suanfarma, Teva pharmaceuticals, Macleods, Intas Pharmaceuticals, Zydus Cadila, Glenmark, Aristo pharmaceuticals and other Indian players in the Pharmaceutical industry.

Being a customer-centric company, Century Pharmaceuticals strives hard to satisfy changing customer needs.They have an internal policy that once a customer is always the customer. Moreover, they empower customer’s business growth by satisfying their special quality and other needs and encouraging cross-selling.

“ We are dedicated to develop

innovative and cost-effective products for the future for better health for all.

A GLIMPSE OF THE INDIAN PHARMACEUTICAL INDUSTRY

Indian Pharmaceutical Industry is at a vantage point.

Several new industries are being set up and the quality standards and systems are being upgraded. It is expected that there will be some attrition of the smaller and less quality conscious manufacturers while those which have strict compliance with GMP will get better opportunities. The Indian quality standards are being appreciated in several markets and they have a distinct edge over competitors owing to

“

large volumes being manufactured cost-effectively for our 1.3 billion people.

CORPORATE CULTURE

Century Pharmaceuticals holds a transparent system and is an innovation driven company that encourage new ideas which help the company to improve the quality and costs from time to time. With a competitive spirit and constant encouragement at Century Pharmaceuticals, employees strive to bring about positive changes consistently.

11

SECRET BEHIND THE SUCCESS

Century Pharmaceuticals has an excellent track record both in terms of service and quality standard of products and always maintains excellent relationships with customers that support the company.

Further Dr. Janak Sheth shares, “In real life the markets move in cycles and if we support the customers during a difficult period, they maintain their loyalty during slack times.”

• • • • • • • • • •

FEATHERS IN THE CAP 2007-Gold medal from Lockheed Martin for best innovation in Biotech technology DSIR recognized R and D unit 2008 2010 - New US FDA approvable manufacturing plant.

2012- MSME award year 2012 by FGI, Gujarat Fair Business Practices (Indian Council for Fair Businesses) Gold Medal for excellence in Business Practices (Switzerland) Excellence award for Exports (Indian council for Small & Medium size exporters) Excellence for Innovation, Quality, Productivity, Management (IES, India) “Dr. Janak K Sheth” has been awarded as Top 30 CEO on Innovation CEO of the year 2014.

Quality Mark award for two year consecutive year 2016 and 2017

CORPORATE SOCIAL RESPONSIBILITIES

Business is not just marketing, sales and profits. One of the major challenges of modern world is to save the environment. Century Pharmaceuticals is a green company with a zero discharge effluent policy. Not only this but they recycle most of the treated water and control fresh water use. They also have solar lights for all lighting purpose and they recharge bore wells with the rainwater in their premises. Presently, they are generating about 50% of their power needs with the a rooftop solar power plant.

ROAD AHEAD

Century Pharmaceuticals is poised for a higher level of growth and planning to expand its geographic reach and product range both. Owing to this flair for exports and a desire to make the best quality product, and in the coming days, the company plans to expand its footprint in more difficult markets while growing rapidly on the home front.

12

Yes, I would like to subscribe Prime View Magazine

­ ­

­ ­

­

India's Leading Pharmaceutical Companies to Watch in 2020

Company Name

Management

ALPHA DRUG INDIA LTD

Alpha Drugs is committed to improve people’s lives. Alpha Drugs aim’s to provide patients with better access to high quality and cost eective medicines. Contributing towards better healthcare through innovation.

Â

Â?

Â? Â?

Â?

Â? Â

Â?

� ­ €

‚

Director

BRILLIANT INDUSTRIES LIMITED

Vice President

CENTURY PHARMACEUTICALS LTD

Managing Director

INDIAN HERBS RESEARCH & SUPPLY CO LTD

Â

Milan Laboratories (India) Pvt. Ltd. is one of the leading Pharmaceutical Manufacturer and Exporter from India. An ISO 9001:2008 and WHO-cGMP certiďŹ ed company, is a Govt. Recognized Star Export House and a winner of various awards for Quality Excellence and Outstanding Export Performance.

Lanolin is synonymous with Rolex Lanolin Products Limited (RLPL). RLPL has made rapid strides over the years and is the undisputed market leader today.

RLPL is also an Export House and its products meet/exceed all national and international standards.

Shubham Pharmachem is a merchant export organization with core competencies in Active Pharmaceutical Ingredients, Herbal extracts, Nutraceuticals ingredients and cosmetic ingredients.

Chief Executive OďŹƒcer

MILAN LABORATORIES (INDIA) PVT LTDv

ROLEX LANOLIN PRODUCTS LIMITED

CEO

Managing Director

SHUBHAM PHARMACHEM PVT. LTD.

SMS PHARMACEUTICALS LTD

Chairman & Managing Director

Founder

Vivan Life Sciences Pvt. Ltd

Indian Herbs objective is to be the world’s leading herbal human and animal health care products manufacturing company, respected and trusted for its ability to produce high quality result oriented products based on original research.

Lifelong group is a diversiďŹ ed group with interests in manufacturing of auto components and medical devices and services in the areas of investments, education, and software & event management. The group’s annual revenues are in excess of $125 million.

Â?

Century Pharmaceuticals Ltd is in the business of manufacturing APIs for over three decades. We oer various kinds of services – in addition to supplies of APIs, we undertake long-term contracts for manufacturing intermediates and development of new Active Pharmaceutical Ingredients as per your requirement.

Chairman

LIFELONG MEDITECH LIMITED

Description

Founder & Director

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started o as a single facility – single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments.

VIVAN Life Sciences is a Knowledge driven and Technology based innovative Global Enterprise, oering higher end synthesized products and services, for various industrial verticals, ranging from Pharmaceuticals, high-end chemical to product - innovation companies.

Investment Opportunities in the Pharmaceutical Industry in India

18

The pharmaceutical industry in India is among the most progressive and advanced among the developed countries and has offered amazing opportunities for employment to a huge number of people. Besides, now the industry is offering excellent investment opportunities for investors from all over the world.

Present-day, the pharmaceutical products that are manufactured in India, they are exported to over 200 countries across the world with the annual turnover for products exported to the US along with running to several billion.

The Indian pharmaceutical industry has witnessed phenomenal growth in terms of product development, usage and infrastructure, and technology in the last few years. And it is poised for greater growth in the coming days.

The major factor behind the increasing opportunities for investors is the huge population of the country that presents a tremendous potential for clinical trials in India. Another major factor behind these opportunities is the availability of cost-effective sources for the production of generic drugs. Research and development works are being carried out on a steady scale and the expense incurred for such activities are very low, which makes it easier to continue the process.

There are a lot of laboratories in India that are of world-class quality and are able to make use of the latest technology. The balance of trade in the field makes it more fascinating for foreign companies to invest in India pharma.

In 2005, the GATT (General Agreement on Tariffs and Trade) was singed that allow the country to recognize global patents. Especially because of the abolishment of licenses for different drugs and pharma products, foreign companies are getting Indian companies a good investment destination.

The Indian Ministry of Chemicals in charge of the pharma industry allows a hundred percent foreign investment in Indian pharma companies, provided they follow some government regulations and in case of indigenous products that have patents recognized by the Indian Patent Act, there is also no price control.

These government initiatives make investment prospects attractive, as national and international companies can get maximum benefits.

Apart from the above steps, the government has also simplified procedures for allowing drug development and included tax breaks for the sector is on the way to provide additional support for Homeopathy, Siddha, Yoga, and Ayurveda drug, making investment opportunities more attractive on both national and international level.

Besides, India has a population with skilled manpower and offers low-cost advantages in the fields of manufacture and research. It will attract a lot of investment related to the outsourcing of R&D and manufacturing from multinational companies. These countries are going through spiralling costs in manufacturer couple with patents, which are expiring. It will drive these companies to outsource their manufacturing and research activities to the country and invest in Indian companies.

Overall India offers great potential as a center for clinical trials for foreign companies and a center where they can expand biosimilars and biopharmaceuticals and has great investment opportunities.

19

INDIAN HERBS SPECIALITIES PVT LTD TACKLING THE NEEDS OF ANIMAL HEALTH INDUSTRY WITH AYURVEDA With its legacy dating back to 1951, Indian Herbs Specialities Pvt. Ltd. remains at the very forefront of the world of animal healthcare with its market-leading products, multiple awards and a commitment towards better health care and productivity enhancement of animals.

As better and economical alternatives to imported vitamins and amino acids, Sushiel Agrawal succeeded in developing Natural Vitamin C, E, Choline as well as methionine and lysine etc.

As per ORG veterinary market survey reports, Indian Herbs achieved 4th ranking in 1992 overtaking leading Veterinary companies.

Creating a benchmark of quality, safety, and efficacy, Indian Herbs sets the standards for herbal veterinary products that others only struggle to achieve. It holds depots in every state and UT, separate field force for livestock, poultry and aqua fields, more than 750 stockists and 15,000 veterinary retail outlets throughout the length and breadth of the country.

Besides being a top herbal AHP company in India, Indian Herbs’ products are also exported to more than 50 countries. Though China holds No.1 position in the world market of herbal human health care products, the distinguished work of present Chairman and CEO of Indian Herbs, Sushiel Agrawal, has put India on No.1 position as a pioneer in the world market of herbal veterinary products.

FOUNDATION WITH GLOBAL GROWTH POTENTIAL Around independence in 1947, the animals were not treated well, as all allopathic veterinary medicines were being imported, they were expensive and not easily available. Shri Ram Lal Agrawal, a freedom fighter decided to develop herbal medicines for animals and founded Indian Herbs in 1951.

Dr. Sushiel Agrawal, the current Chairman and CEO of Indian Herbs joined his father’s business in 1968 and gave practical shape to the concept of Veterinary Ayurveda, on modern scientific lines including pharmacological, toxicological and controlled clinical studies.

20

SERVICE PORTFOLIO

Indian Herbs offers a wide range of more than 200 herbal Medicines and nutritional products for livestock, poultry, canines, equines and aquaculture.

Since 1998, Indian Herbs is also engaged in research, development and manufacturing of unique Ayurmed Specialities (Human Herbal Medicines), particularly for those therapeutic segments where modern system of medicine does not provide satisfactory cures.

DISTINGUISHING FACTORS A well-equipped modern R&D Centre recogn ized by Ministry of Science, Govt. of India.

Developed suitable Methods of Analysis and Standardisation for Herbal Veterinary Prod ucts based on finger printing, using chromato graphic techniques.

Besides clinical studies, advanced scientific studies like Cell Culture Studies, Nutrigenomic,

THE MAN BEHIND VISION Sushiel Agrawal, the present CEO of the company was the first to introduce the concept of herbal growth promoters in Poultry and Livestock in place of hormones, steroids, antibiotics etc. Sushiel Agrawal has so far personally authored 53 research papers published in eminent journals and magazines.

Sushiel Agrawal presented the science of Veterinary Ayurveda at many Conventions and Seminars of Veterinary Scientists, Consultants, Nutritionists and Farmers in India and around 50 countries of the world.

Indian Herbs products have been approved for organic farming in EEC etc. Sushiel Agrawal was invited as Guest Speaker at First International Conference for Organic Animal Farming in USA in 2006.

He was a panel member in a TV programme organized by Doordarshan in the late 90s on the use of herbal veterinary products for health care of pets and domestic animals. Appreciating the concept of Veterinary Ayurveda, BBC telecast the programmes on `Country Watch’ and 'Country File' programmes in 1994.

Metagenomic Profiling, Morphometry, Histo chemistry and Histomorphology Studies, Digestibility and Metabolic Modulation Studies, Profiling by ELISA etc., on the products.

Over 200 Veterinary Scientists have been awarded higher degrees such as Ph.D., M.V.Sc., for conducting research on Indian Herbs products.

More than 1000 research papers published on Indian Herbs’ products.

Many quality certifications like GMP, GMP Plus, ISO 9001:2015, OHSAS 18001:2007, HACCP, FSSAI. 22 Patents including a unique drug delivery system.

Sushiel Agrawal (CEO)

JEWELS IN THE CROWN National Awards for: Outstanding Entrepreneurship (2007), Outstanding R&D achievements (2008), Outstanding Quality Products (2010), Business Innovation (2014-15) by Ministry of MSMEs, Govt. of India as well as State Awards for Export Excellence (1995-96 to 2018-19) and Product Quality Excellence (2009-10) from Govt. of U.P. AIMA - Dr. J.S. Juneja Award for creativity and innovation in SMEs with cash prize by All Indian Management Association, Delhi in 2007.

“

Creating a benchmark of quality, safety, and efficacy, Indian Herbs sets the standards for herbal veterinary products that others only struggle to achieve.

“

21

The National Academy of Veterinary Sciences (India), New Delhi conferred Hony. Fellowship to Sushiel Agrawal in 2012.

Indian Federation of Animal Health Companies, Mumbai presented INFAH Award 2017 to Sushiel Agrawal.

Maintaining No.1 position in herbal AHP market in India since 1951, Indian Herbs is the first company to receive approval from the Export Inspection Council of India and Status of 2 Star Export House from the Ministry of Commerce & Industry, Govt. of India.

When the products of Indian Herbs became popular, unscrupulous companies ventured into this field, without any scientific backup, on the basis of low prices, without caring for quality and efficacy. This caused damage to image and credibility of herbal products for some time.

MNCs lobbied that herbal products are not scientific.

Indian Herbs had to invest a lot to arrange extensive clinical trials in comparison to allopathic and other herbal veterinary products to prove the efficacy, safety and justify the prices of the products.

CORPORATE ETHOS FOR CUSTOMERS

CURRENT SCENARIO There is increasing interest in herbal (natural) products for use in animals due to the side effects, withdrawal problems, residual toxicity, resistance development and undesirable consequences associated with synthetic and chemical products.

MAJOR CHALLENGES AND OPPORTUNITIES The natural products need to be scientifically developed with clearly defined modes of action, rigid standardisation and quality control. Consumers of milk, meat and eggs are now more aware and look for healthy and nutritious foods, free from use of pesticides, antibiotic growth promoters and other chemical products.

HICCUPS ON THE WAY In the B.V.Sc. curriculum of Veterinary Colleges, only Allopathic Veterinary Medicines were taught.

Therefore, Indian Herbs had to make extra efforts to educate the Veterinary Practitioners about the products.

22

Indian Herbs provides the right products with dependable quality, efficacy and safety, which helps to gain the trust and confidence of customers. They seek suggestions from distributors and users for the development of new products required by them and improvement in the existing products and the services.

ROAD AHEAD Because of the increasing trust in Indian Herbs’ products, the market share is regularly increasing both in India and the international market. It is increasingly felt that the future will belong to medicines and health foods based on natural products and Indian Herbs is fully equipped to meet these requirements.

GUIDING FORCE • • •

Shri Sudhakar Agarwal- Director (Production) Shri Gaurav Agrawal- Director (Marketing) Shri Vipul Agrawal- Director (Finance)

Top Tech Advancements in IndiaN PHARMACEUTICAL Industry Today, India is the largest provider of generic drugs on the global level. The pharmaceutical sector of India supplies more than 50 percent of global demand for different vaccines, 40 percent of generic demand in the US and 25 percent of all medicines in the UK. The industry is under continuous pressure to discover and develop new drugs targeted toward increasingly complex diseases that means the industry must use innovative technologies that will help them ramp up research and development, manufacturing and analytical capabilities and also enable them to be competitive and compliant.

Apart from its growth, the pharmaceutical industry of India is still unclear about how the latest technologies are going to impact drug development as well as commercialization. Some industrial experts feel that emerging technologies like 3D printing and AI will change to the business models, workforce, cybersecurity and operations. Here are the top trends that are making an impact on the Indian pharmaceutical industry.

Top Technology Innovation in Pharma Industry of India: 3D Printing

Nanotechnology

24

3D printing is amazing in building the pill by spreading layers of the drug on the top of one another until it reaches to the right dose.

The tech innovation allows the pill to deliver a higher dose of medicine up to 1000 mg. This is porous enough to dissolve rapidly. It is great for patients having problems swallowing their medications.

Nanotechnology is the microscopic technology, which ranges on a scale of between 1 to 100 nanometers. This microscopic technology can easily travel in the human body in the bloodstream. It helps in the delivery of anti-cancer drugs and decreases toxicity. Nanotechnology can easily track patients who take their medicines that encourage raised adherence.

Nanobots

Bioinformatics

Medication Therapy Management

Nanobots are made of two different words i.e. nanotechnology and robots. A lot of medical research institutes are researching the potential use of microscopic robots. These robots are widely-known as nanobots. This is consumed by the patient in the form of injections or pills.

Recently, research showed that the researchers will include the use of informatics to drive the development of therapies to bring value to the healthcare system and patients at the lowest price. Here, programs on social media become one of these tech drivers. Under this concept, patients will be able to connect online to share their experiences with different diseases.

Medication Therapy Management services involve drug use review, drug dose adjustment, comprehensive medication reviews, order and review lab tests, immunization and many more. MTM is effective in enhancing medication use and patient outcomes in patients suffering from chronic disease. It will also cut the price and enhance the quality of care and patients safety.

So these are the top tech advancements in the Indian Pharmaceutical industry. We hope you have enjoyed the article. To read more such interesting content, often visit our website.

25

Janitri Innovations Exceptional Tech-based Innovations in Healthcare The triumphant journey of Janitri innovations commenced with visiting more than hundred plus hospitals across India for the needed identification and validation. After which the company embarked on the prototype and developed it with few collaboration in primary, secondary and tertiary hospitals for the pilot purposes. Based on these pilot feedbacks, they developed the minimum viable product and incepted commercial pilots. At present, their presence is more than forty plus hospitals in seven plus states across India at the moment.

Genius and Genuine Services for Mothers and Newborns KEYAR is an affordable, easy to use and wearable fetal heart rate, uterine contraction and maternal heart rate monitoring device for Arun Agarwal intra-partum care. KEYAR displays fetal heart rate, uterine conFounder traction & maternal heart rate in an easy format which is interpretable by a low skilled health worker. KEYAR communicates with their mobile application DAKSH which is an intelligent intrapartum monitoring mobile application for digital partograph and paperless labor monitoring. DAKSH allows the staff nurse to register and enter vital signs of a pregnant woman. It reminds the staff nurse to monitor the labor vitals, as per the standard WHO intrapartum protocol. It also generates alerts in case of complications, based on an in-built algorithm.

A Journey started off with Small Observations to Achieving a Breakthrough Arun Agarwal, Founder of Janitri Innovations, is native to a small town in India. Since his childhood he witnessed many of his family members and neighbors suffer from health problem like diabetes, malaria, jaundice, pneumonia and many more. During his undergraduate study, he realized that technology can solve most of the healthcare related problems and that motivated him to pursue a post-graduation in biomedical engineering. After completing his PG, he started visiting villages in India to explore health related problems. While talking to community, pregnant women, mothers, midwives and doctors, Arun was able to connect the dots with his childhood memories. He realized 26

that maternal & child health is a huge problem in India and many deaths can be prevented by simple affordable innovations. Further, Arun visited 100+ healthcare settings across India to explore problems related to maternal & child healthcare and decided to work on the problems through Janitri Innovations.

Overwhelmed with the Support came from Government As a firm, Janitri is privileged to receive grant support from Bill and Melinda Gates Foundation, BIRAC, Government of Karnataka (Startup Karnataka scheme), VILLGRO, Grand Challenges Canada etc. These grants helped the company in product development in pilot. Apart from grants, they won Tie Anthah Prerana, Qualcomm Design Challenge, LES APAC conference, Falling Walls etc.

Rural India has Biggest Healthcare Challenges, also Home for Opportunities In India, mass lives in rural areas hence major challenges and opportunities exist there. There is a huge potential of affordable healthcare services/technology for the mass population that lives in rural area. Defined steps need to put forward along with rectified innovations, solutions and services at right time right place. That is inclusive of early screening, diagnostic, monitoring, telemedicine etc. in the areas of cardiac, neuro, maternal and child health etc.

Janitri’s Mantra: Do early, Fail Early and Ameliorate Janitri Innovations follow the process of “do early, fail early� and innovate on routine basis for their product development, pilot, and internal process etc. That offers room for team members to strive on and think-out-of-the-box hence creativity comes with innovation. The company efforts on testing the product or feature in the hospital (urban and rural) in real time to receive the feedback of the relevant stake holders (nurses, doctors, patient). Based on the feedback, they take quick decision on modification or inclusion or removal of any technology component. Major factor

Developing sustainable technology to improve maternal and child healthcare.

To Serve Customers Better, Validate their Feedbacks to Real Terms As an initial step, Janitri provides the best-in-class products, services and maintenance. Their main strategy is, frequent and regular interaction with the customers, so as to get their view/comment/feedback on the overall product. Further, the company validate and implement that in their internal process and try to incorporate that feedback into the product to ensure that customers/users should get what they are looking for. This will help us to build the relation and improve the product.

Striving on Innovative Solutions on Maternal and Newborn Mortality Janitri Innovations is focusing on maternal and child health problems as maternal mortality and newborn mortality is still a major concern across the world. They believe that more than 80% of these problems can be solved by simple innovations in a sustainable manner. Therefore, the company strive on MCH and envision to expand across the globe with their current product.

URL: www. janitri.in 27

THE TRIALS AND TRIBULATIONS IN PHARMA SECTOR OF INDIA Today, India has become the largest provider of generic drugs on the global level after supplying more than 50 percent of global demand for various vaccines, 40 percent of generic demand in the US and 25 percent of all medicines in the UK. The pharmaceutical market has become the largest exporter of medication by volume. In terms of market size, the Indian pharma industry is expected to grow over 15 percent per annum during the same period. The market is expected to progress to US$55 billion by 2020, thereby emerging as the sixth-largest pharmaceutical market globally by its size.

But 2019 ended on a sour note for Indian pharmaceutical companies, with the Nifty Pharma index down about 10% so far. When it is compared with the Nifty 50 index has risen about 10%. And, unfortunately, the pharmaceutical firms may not be out of the woods in 2020. The US FDA inspections increased considerably in 2019 and led to the Indian drug makers getting about 23 warning letters. Today, Indian companies account for about one official action-indicated letter. Indian companies account for about one official action-indicated letter for every six inspections that are worrisome.

Most pharma stocks that got observation letters, OAI letters, or warning letters went into a tailspin. As the US FDA inspects over 400 manufacturing plants in the country every two years, the risk of adverse observations remains high.

30

Here what could be the solution? Its control over costs, with the added element of curtailing capacity expansion. It would boost the return on equity in the long run. Still, some critical risks for domestic pharma could come from issues like NLEM and price controls. In our country, drugs are assumed as expensive, but any move to review costs could severely eat into the margins of pharma companies. The domestic pharma market has been progressing at a rapid pace that aided profitability enhancements. If domestic pricing pressure increases, margins and profitability could be eroded.

A good thing is that the earnings downgrade cycle has moderated. This time, although, the market is factoring in higher potential earnings growth for 2020. Give the heavy and looming overhangs, as high earnings growth could be at a risk. If the actual progress rate contracts, the Indian pharmaceutical industry of India could still be in for topsy-turvy 2020.

Road Ahead Medicine spending of the country is projected to grow 9-12 percent in the next five years, leading India to become one of the top 10 countries in terms of medical spending.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards the chronic therapies for diseases like cardiovascular, anti-diabetes, anti-depressants and anti-cancers, which are on the rise. The government has taken steps to cut costs and reduce the expenses of healthcare. Speedy introduction of generic drugs in the market has remained in focus and is expected to support the Indian pharmaceutical companies to gain profit.

Clinical Trial 31

ROLEX LANOLIN PRODUCTS LIMITED PRODUCING A DIVERSE PORTFOLIO OF ICONIC LANOLIN AND ALLIED PRODUCTS WITH EXCELLENT QUALITY Gaining prominence in recent years, the pharmaceutical industry of India has turned into a sunrise sector and has served as a significant connection between the industrial and the chemical segments of the economy.

Since its inception, the lanolin manufacturing company, Rolex Lanolin Products Limited (RLPL) has strived to penetrate newer areas of technology and business. The specialty company was established in 1967, and is headquartered in Mumbai. It serves several of its customers (many being in the pharmaceutical sector) with its differentiated lanolin products.

RLPL is certified under ISO 9001:2008 (QMS); ISO 14001:2004 (EMS); BS 18001:2007 (OHSAS) and EFfCI (cGMP) supported by an excellent team of professionals, led by highly experienced leaders, and a state-of-the-art manufacturing + R&D facilities.

The firm has made rapid strides over the years and is one of the undisputed market leaders today known for supplying high quality products. RLPL is also an Govt Recognised Export House, AEO Registered and its products meet/exceed practically all national and international standards.

Uncompromising insistence on high-quality standards, continuous innovation and the conscious commitment and dedication to providing value for money to the customer have made RLPL a renowned name.

JOURNEY SINCE INCEPTION

Rolex Lanolin Products Limited was formed in 1967 under the aegis of Hasmukh N. Zaveri with a small manufacturing plant in the Tardeo area of Mumbai 32

and its first office in Princess Street - the Heart of Mumbai's Chemical market. In 1971 Rolex set up a larger plant as a Registered Small-Scale Industry Unit at Andheri. It was here that the commercial production of Lanolin commenced successfully.

In 2015, RLPL successfully shifted its manufacturing facilities to a new state-of-the-art plant at Vapi, Gujarat. The facility is spread over 6972 square meters with an enhanced licensed capacity and an in-house laboratory facility for Quality Control and Assurance.

DIFFERENT PRODUCTS AND SERVICES

From offering just 3 grades of Lanolin in the early 80’s, RLPL offers over 50 grades today. Research & Development has always been crucial to their operations and success. They have successfully developed many customized specifications as per their client’s specific requirements using different methodology but maintaining the key features and characteristics of Lanolin. The new in-house R&D facility (opened in February 2019), Woolfat Research Centre (WRC), is a 100% owned subsidiary of RLPL. WRC offers services for the development of various Lanolin based blends and formulations for cosmetics, topical pharmaceuticals, industrial, and household products.

AWARDS, ACHIEVEMENTS, AND RECOGNITIONS

RLPL’s success in developing Lanolin indigenously and commercially manufacturing the same strictly to the Indian Pharmacopoeia standards for the first time in India won it the appreciation from the "The Invention Promotion Board" of the Central Govt. sponsored National Research & Development Corporation. They were thus presented in 1974 with a coveted Bronze Import Substitution Award and Certificate of Merit by the then honourable Union Minister for Commerce and Industry of India.

THE MEN BEHIND RLPL & THEIR BRANDS Hasmukh N. Zaveri, Founder & Chairman, RLPL, is a visionary having introduced LANOLIN to India the very first time in mid-sixties. His son Hasit Zaveri, versatile and ambitious, has been instrumental in the company’s growth and expansion and joined his father in the mid-eighties and is the current Managing Director of the company. They have extensive experience and industry knowledge.

With their excellent guidance and dynamic leadership, Jash Zaveri (the third generation who joined the family business in 2017 after completing his Masters from London Business School) is now focused on taking RLPL to a higher plane.

Their further success in developing Lanolin as a Cosmetic Intermediate won them the appreciation from the Federation of Associations of Small-Scale Industries of India (F.A.S.I.I.), and were presented in 1984 with the A. R. Bhatt Entrepreneurship Award by the honourable Vice President of India. In 2004, RLPL received the Bombay Industries Association’s (B.I.A.) Excellence Award. Rolex Lanolin completed 50 years in the Lanolin business in 2017 and has over fifty various products to offer, as well as over 500 clients across the world including PSU’s, MNC’s and leading FMCG companies. Today Rolex Lanolin is compliant with various internationally acceptable standards and accreditations.

Producing a Diverse Portfolio of Iconic Lanolin and Allied Products with Excellent Quality.

WHAT IS LANOLIN? Lanolin is a key ingredient used in topical pharmaceutical, cosmeceutical, cosmetic, personal care and skincare products. It is a natural waxy substance that is derived from sheep’s wool.

Lanolin and its derivatives are a one-stop solution for skin problems. It is the ultimate emollient, emulsifier, stabilizer and moisturizer. In the case of dry skin and psoriasis, it forms a film on the skin that limits water loss across the skin surface whereas ingredients such as petroleum jelly moisturize by retarding the evaporation of water.

“ 33

Deficiency of vitamin D is devastating to your skin, but lanolin contains this crucial vitamin D which gives protection to the skin by boosting its immunity and maintaining the skin barrier. Many skincare products use petroleum jelly, sulfates, parabens and many more chemicals that are harmful to your skin.

Lanolin was used since ancient times by Greeks as a powerful emollient to soothe, protect, and heal the skin.

Lanolin is not only a hundred percent natural but also free from cruelty to animals. Lanolin is biodegradable, non-toxic and sustainable.

34

CORPORATE VALUES FOR RLPL The RLPL team ensures that the brand values are never compromised while working. With zeal to positively impact people’s lives through compassion, excellence in product quality, affordability and marketability empowered with innovation to enhance attributes of products and processes. The company believes in strong partnerships, which leads to value enhancements, trust and transparency for customers as a part of its values.

Top Pharmaceutical Companies in India You should Know India is on the leading position in the generic drugs market globally and is the largest provider of the same across the world. Indian pharmaceutical industry manufacturers over 50 percent of the global medicine including 40 percent demand in the US and 25 percent of all demand in the UK. Top Pharma companies in India are generating effective formulations to meet the increasing demand for pharmaceutical products across Indian and the world.

Medicines had been through a lot of innovation in the past few years and with every step, they have grown.

Many new companies have emerged well with their innovation, development, and contribution to healthy mankind. The pharmaceutical industry is now experiencing the wave of these emerging top Pharma Companies in India which are flourishing at a faster rate with their innovative solutions.

In this article, we have summed up some of the best Indian pharma companies which offer quality products at an affordable range. Besides, these companies hold brand value and market reach;

Sun Pharma is one of the top pharma companies in India; it was founded by Dilip Shanghvi in the year 1983. The firm recorded more than 72 percent of its sales from overseas market, mainly in the US, accounting for above 50 percent of its turnover. It has manufacturing units set up in different companies including MĂŠxico, Brazil, US, Canada, and Israel.

Headquartered in Mumbai, Cipla is known for developing medicines to treat respiratory, arthritis, diabetes, cardiovascular disease, weight control, depression, and many other medical conditions. The company holds 34 manufacturing units in 8 locations across the country.

36

Founded in the year 1986, Aurobindo Pharma Ltd is a leading pharmaceutical company manufactures anti allergies, antibiotics, gastroenterological, central nervous system products and cardiovascular products. The firm is involved in a range of products including formulation, pharmaceutical ingredients, and organic intermediates.

One of the leading pharmaceutical companies in India, DM Pharma offered medicines that are capable of treating the most difficult health issues. Over the years, the company has grown to the leading name in the industry with its impeccable contribution towards the healthcare sector.

A famous and trusted name in the pharma industry, H. L. Healthcare has been involved in the manufacturing supply, trading and franchise business for a long time. The firm works with the motive to prevent, diagnose, alleviate and cure diseases. H. L. Healthcare delivers an exceptionally well and highly effective range of drugs.

Chandigarh based Pharma Company; Apikos Pharma has made into the list of top pharma companies in India because of its rapid growth. The firm is known for providing world-class Pharma formulation and also deals with the research and invention of new pharma products for several health-related issues.

Among the leading pharmaceutical companies in India, Glenmark Pharmaceuticals is a famous name. It was founded in 1977 by Gracias Saldenha. Its product range includes vaccines and medicines. Initially, the firm sold its products in India, Africa, and Russia and is now dealing all across the world.

So these are the leading names in India pharmaceutical. We hope you enjoy the article. If you want to add any name, please let us know.

37